0001567619-23-001946.txt : 20230206 0001567619-23-001946.hdr.sgml : 20230206 20230206173108 ACCESSION NUMBER: 0001567619-23-001946 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230202 FILED AS OF DATE: 20230206 DATE AS OF CHANGE: 20230206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jones Erin CENTRAL INDEX KEY: 0001754278 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38663 FILM NUMBER: 23591705 MAIL ADDRESS: STREET 1: C/O GRITSTONE ONCOLOGY, INC. STREET 2: 5858 HORTON STREET, SUITE 210 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gritstone bio, Inc. CENTRAL INDEX KEY: 0001656634 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 300 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 871-6100 MAIL ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 300 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: Gritstone Oncology, Inc. DATE OF NAME CHANGE: 20151023 4 1 doc1.xml FORM 4 X0306 4 2023-02-02 0 0001656634 Gritstone bio, Inc. GRTS 0001754278 Jones Erin C/O GRITSTONE BIO, INC. 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 0 1 0 0 See Remarks Common Stock 2023-02-02 4 A 0 252845 0 A 305914 D Represents Restricted Stock Units ("RSUs") 170,366 of which vest semi-annually over four years and 82,479 of which vest annually over two years from February 1, 2023, in each case, subject to the Reporting Person's continuous service to the Issuer on each such date. Each RSU represents a contingent right to receive one share of common stock of the Issuer. Includes 252,763 RSUs which are subject to vesting. Executive Vice President & Chief Operating Officer /s/ Vassiliki (Celia) Economides, Attorney-in-Fact for Erin Jones 2023-02-06